Evidence map›Paper›PMID 38579362›Full record

ArticleEBioMedicine2024

Retraction notice to 'MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway' [EBioMedicine 46 (2019) 66-78].

Wei-Wei Wang, Zhi-Hua Zhao, Li Wang, Pan Li, Kui-Sheng Chen, Jian-Ying Zhang, Wen-Cai Li, Guo-Zhong Jiang, Xiang-Nan Li

RetractedOpen access · goldAbstract readRetraction Notice
PubMed Full text at PMC Publisher
In one paragraph

Article in EBioMedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 94% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Wei-Wei WangDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China.
Zhi-Hua ZhaoDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China.
Li WangDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China.
Pan LiDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China.
Kui-Sheng ChenDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China.
Jian-Ying ZhangInstitute of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, 450052, China.
Wen-Cai LiDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China. Electronic address: liwencai@zzu.edu.cn.
Guo-Zhong JiangDepartment of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China; Department of Pathology, School of Basic Medicine, Zhengzhou University, Zhengzhou, 450002, China; Henan Key Laboratory for Tumor Pathology, Zhengzhou, 450052, China. Electronic address: guozhongjiang@zzu.edu.cn.
Xiang-Nan LiDepartment of Thoracic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, China. Electronic address: fcclixn@zzu.edu.cn.
Zhengzhou University · CNHenan Cancer Hospital · CNFirst Affiliated Hospital of Zhengzhou University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38579362
PMCPMC11004689
OpenAlexW4393962367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.